–
Telomir Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.14
FY22:
−0.85
FY23:
−3.94
FY24:
−12.2
FY25:
−10.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.14
FY22:
−0.85
FY23:
−3.94
FY24:
−12.2
FY25:
−10.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.14
FY22:
−0.85
FY23:
−13.1
FY24:
−16.5
FY25:
−10.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.14
FY22:
−0.85
FY23:
−13.1
FY24:
−16.5
FY25:
−10.4
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.